STOK
Stoke Therapeutics Inc
25.30$
-1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.8% | -10.1% | +50.0% | -4.7% | -7.4% | +49.8% | -5.5% | -6.3% | +16.1% | +5.9% | -11.1% | |
| – | -6.4% | -10.2% | +53.7% | -14.6% | -8.2% | +61.4% | -28.1% | +0.9% | +12.2% | +19.9% | -12.0% | |
| – | +0.8% | -6.7% | +8.3% | -22.5% | -14.7% | +114.7% | -63.1% | -17.8% | +1.0% | +84.8% | -29.3% | |
| – | -6.2% | -11.3% | +57.9% | -15.2% | -9.3% | +64.7% | -30.7% | +0.2% | +14.6% | +20.7% | -14.8% | |
| – | -33.3% | -82.8% | +2,672.7% | +126.6% | +1.3% | -13.4% | +167.7% | +568.1% | -27.1% | -22.3% | +42.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.8% | -5.7% | +0.3% | -5.9% | -30.5% | +33.6% | -12.8% | +5.2% | +26.5% | -26.6% | +0.0% | |
| – | +22.3% | +15.5% | +25.0% | +12.1% | -19.7% | +11.6% | -13.4% | +7.9% | +38.7% | -29.5% | +2.8% | |
| – | -17.5% | +7.3% | +2.9% | +0.9% | +1.0% | +1.2% | -2.3% | +26.7% | +3.4% | -19.1% | -24.2% | |
| – | -44.9% | +24.0% | +87.7% | -37.0% | +0.5% | -12.5% | +97.3% | +36.1% | -15.9% | +38.5% | -29.9% | |
| – | -7.8% | -12.0% | +72.9% | -4.4% | -1.3% | +52.9% | -4.3% | -8.0% | +14.4% | +12.0% | -12.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.6% | +2.9% | +20.6% | +1.0% | +1.2% | +4.2% | -1.8% | +0.4% | -0.4% | +8.0% | +4.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.